What is the most profitable industry in the world, this side of the law? Not oil, not IT, not pharma.
It's *scientific publishing*.
We call this the Drain of Scientific Publishing.
Paper: arxiv.org/abs/2511.04820
Background: doi.org/10.1162/qss_...
Thread @markhanson.fediscience.org.ap.brid.gy 👇
Posts by Anna-Victoria Holtz
It's fabulous to welcome our students and alumni back to @mpidr.bsky.social for the 6th IMPRS-PHDS Graduate Workshop! We are looking forward to two days of research updates and networking as well as mini-workshops on science communication and mastering Q&A sessions!
💡💡💡We are delighted to welcome @imprs-phds.bsky.social students and their supervisors to the Annual Academy 2024 @mpidr.bsky.social. We're looking forward to two more days of student and faculty presentations, networking, and sharing future research endeavors. 🎓🎓🎓
#demography #phdlife #PhD
On a personal note. Neurodegenerative diseases also affect those who want to tackle them.
gofund.me/247f9d35
Today was the last day of my research stay @cedemografia.bsky.social. I had the great opportunity to work with Iñaki Permanyer and Jordi Guma together on a comparative study on #dementia-related morbidity trajectories of #Catalans and #Germans. Excited to share insights in the coming year.
Last week I had the chance to present my project on the healthcare utilization of people newly diagnosed with dementia at the cooperation conference "Gesundheit Gemeinsam 2024" in Dresden. The perfect opportunity to discuss with public health, medical, epi and social science researchers
Das ESF-Team beim diesjährigen 15. Rostocker Firmenlauf im Stadthafen am 26. Juni- leicht erschöpft, aber happy nach dem Zieleinlauf bei bestem Sommerwetter 😎
We found that there is no increased risk of PD for any type of colonoscopy after controlling for death and covariates.
This is work highlights once again that mortality in older adults and confounding by indication need to be taken into account when assessing the risk of disease.